Form 8-K - Current report:
SEC Accession No. 0001437749-21-002350
Filing Date
2021-02-09
Accepted
2021-02-09 16:59:03
Documents
6
Period of Report
2021-02-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnpx20210208_8k.htm 8-K 29212
2 EXHIBIT 1.1 ex_225354.htm EX-1.1 51939
3 EXHIBIT 5.1 ex_225355.htm EX-5.1 17837
4 EXHIBIT 10.1 ex_225356.htm EX-10.1 207439
5 EXHIBIT 99.1 ex_225357.htm EX-99.1 9974
6 img.jpg GRAPHIC 3302
  Complete submission text file 0001437749-21-002350.txt   322227
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

EIN.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38244 | Film No.: 21607362
SIC: 2834 Pharmaceutical Preparations